Telomir Pharmaceuticals, Inc. (TELO) stock
TELONasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.48−0.01 (-1.96%)
Close on Nov 16, 2026Market cap $33.08MP/E –Yield –
Telomir Pharmaceuticals price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Telomir Pharmaceuticals's price to book ratio was 8.1× on Nov 11, 2026, against 6.5× a year earlier. Over the last 3 years it ranged from 5.5× to 325.5×, with a median of 47.2×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 8.1× | +1.7 |
| 2025 | Dec 31, 2025 | 6.4× | −269.5 |
| 2024 | Dec 31, 2024 | 275.9× | – |
See a number that looks wrong?